Previous researches revealed that the levels of serum C3 and C4 positively correlated with the development of the metabolic syndrome and had been identified as important markers relevant to this disease (Meng et al., 2017; Meng et al., 2018; Xin et al., 2018). This evidence concerns the gene C3 and metabolic syndrome.